
Oncologist

No OPD information available
Prostate Cancer
NUT Carcinoma
Renal Cell Carcinoma (RCC)
Bladder Cancer
Bone Tumor
Breast Enlargement In Males
Dry Mouth
Familial Prostate Cancer
Lymphofollicular Hyperplasia
Nephrectomy
Neuroendocrine Tumor
Prostatectomy
Retinoblastoma
Small Cell Lung Cancer (SCLC)
Arun A. Azad is a male medical professional who helps patients with different types of cancer and other health issues like dry mouth and breast enlargement in males. He specializes in treating conditions such as prostate cancer, bladder cancer, bone tumors, and more. Arun A. Azad is skilled in performing procedures like nephrectomy, prostatectomy, and treating rare conditions like NUT carcinoma and retinoblastoma.
Arun A. Azad is known for his excellent communication with patients, making them feel comfortable and informed about their treatment. Patients trust him because he listens to their concerns and explains things in a way they can understand. He stays updated with the latest medical knowledge and research to provide the best care possible to his patients.
Arun A. Azad works closely with his colleagues and other medical professionals to ensure that patients receive comprehensive and coordinated care. His collaborative approach helps in delivering the best outcomes for patients. He has also contributed to research and publications in the field of oncology, with notable work on advanced prostate cancer treatment.
One of Arun A. Azad's notable publications is about a study comparing different treatments for advanced prostate cancer, showing his dedication to advancing medical knowledge. He is also involved in clinical trials exploring innovative treatments for metastatic kidney cancer, showing his commitment to improving patient outcomes through research.
Overall, Arun A. Azad's work has had a positive impact on many patients' lives by providing expert care, staying updated with the latest advancements in medicine, and contributing to research that can lead to better treatment options. Patients trust him for his expertise, communication skills, and dedication to improving healthcare outcomes.
Enrollment Status: Active not recruiting
Published: March 11, 2025
Intervention Type: Drug, Radiation
Study Drug: Ipilimumab/Nivolumab
Study Phase: Phase 2
